Risk of Euglycemic Diabetic Ketoacidosis in Patients Taking Sodium Glucose Transporter 2 Inhibitors Undergoing Endoscopies

Anesthesiology. 2023 Nov 1;139(5):705-707. doi: 10.1097/ALN.0000000000004719.

Authors

Benjamin Steinhorn¹, Scott Cao, James Richter, Rodger White, Jeanine Wiener-Kronish

Affiliation

¹ Massachusetts General Hospital, Boston, Massachusetts (B.S.). bsteinh@stanford.edu.

PMID: 37815471
DOI: 10.1097/ALN.0000000000004719

No abstract available

Publication types

Letter

MeSH terms

Diabetes Mellitus*
Diabetic Ketoacidosis* / chemically induced
Diabetic Ketoacidosis* / diagnosis
Endoscopy
Humans
Patients
Sodium-Glucose Transporter 2 Inhibitors* / adverse effects

Substances

Sodium-Glucose Transporter 2 Inhibitors